Sinopharm Group Co. Ltd (SHTDF) is a publicly traded medical distribution business based in the US which employs around 114,750 staff. Sinopharm Group Co. is listed on the PINK and traded in US dollars. Its current price of $2.425 is 1.9% up on its price a month ago ($2.38).
Finder Award
Finder Award
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Sinopharm Group Co.), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Sinopharm Group Co. is a major part of the PINK, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Over the last 12 months, Sinopharm Group Co.'s shares have ranged in value from as little as $2.3189 up to $3.4929. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Sinopharm Group Co.'s is 0.864. This would suggest that Sinopharm Group Co.'s shares are less volatile than average (for this exchange).
Historical closes compared with the last close of $2.425
| 1 week (2023-11-29) | -6.37% |
|---|---|
| 1 month (2023-11-06) | 1.89% |
| 3 months (2023-09-06) | -14.01% |
| 6 months (2023-06-06) | -23.16% |
| 1 year (2022-12-06) | 6.11% |
| 2 years (2021-12-06) | 22.72% |
| 3 years (2020-12-06) | 39.04% |
| 5 years (2018-12-06) | -22.15% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Sinopharm Group Co. P/E ratio, PEG ratio and EBITDA
Sinopharm Group Co.'s current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6x. In other words, Sinopharm Group Co. shares trade at around 6x recent earnings.
Sinopharm Group Co.'s "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 10.1575. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Sinopharm Group Co.'s future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Sinopharm Group Co.'s EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $24.6 billion (£19.5 billion).
The EBITDA is a measure of a Sinopharm Group Co.'s overall financial performance and is widely used to measure a its profitability.
Sign up for weekly expert share tips
Join 50,000 subscribers who are notified about expert share tips. Plus a chance to win £800!
By signing up you agree to receive emails from Finder and to the privacy policy and terms & conditions.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to buy shares in Catalent? We explain how and compare a range of providers that can give you access to many brands, including Catalent.
Ever wondered how to buy shares in Canopy Growth? We explain how and compare a range of providers that can give you access to many brands, including Canopy Growth.
Ever wondered how to buy shares in Green Thumb Industries? We explain how and compare a range of providers that can give you access to many brands, including Green Thumb Industries.
Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.
Ever wondered how to buy shares in Bionano Genomics? We explain how and compare a range of providers that can give you access to many brands, including Bionano Genomics.
Ever wondered how to buy shares in Genesis Healthcare? We explain how and compare a range of providers that can give you access to many brands, including Genesis Healthcare.
Ever wondered how to buy shares in Sundial Growers? We explain how and compare a range of providers that can give you access to many brands, including Sundial Growers.
Ever wondered how to buy shares in Sensyne Health? We explain how and compare a range of providers that can give you access to many brands, including Sensyne Health.
Ever wondered how to buy shares in Advanced Oncotherapy? We explain how and compare a range of providers that can give you access to many brands, including Advanced Oncotherapy.
Ever wondered how to buy shares in Allergy Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Allergy Therapeutics.